SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041559
Filing Date
2021-08-05
Accepted
2021-08-05 16:00:36
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20210805.htm   iXBRL 8-K 39298
2 EX-99.1 onct-ex991_7.htm EX-99.1 172816
3 GRAPHIC glop1boahyjv000001.jpg GRAPHIC 7888
4 GRAPHIC glop1boahyjv000002.jpg GRAPHIC 22350
  Complete submission text file 0001564590-21-041559.txt   395421

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA onct-20210805.xsd EX-101.SCH 5689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210805_lab.xml EX-101.LAB 19328
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210805_pre.xml EX-101.PRE 11491
8 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20210805_htm.xml XML 3564
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 211148032
SIC: 2834 Pharmaceutical Preparations